Global Contrast Media Strategic Business Report 2023: Growing Preference for Non-Ionizing Radiation-Based Radioimaging Drives Demand for Contrast Enhanced MRI
DUBLIN, March 29, 2023 /PRNewswire/ -- The "Contrast Media: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Contrast Media Market to Reach $6.2 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Contrast Media estimated at US$4.9 Billion in the year 2022, is projected to reach a revised size of US$6.2 Billion by 2030, growing at a CAGR of 3.1% over the analysis period 2022-2030.
X-ray/Computed Tomography (CT), one of the segments analyzed in the report, is projected to record a 1.8% CAGR and reach US$2.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Magnetic Resonance Imaging (mri) segment is readjusted to a revised 3.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 4.5% CAGR
The Contrast Media market in the U.S. is estimated at US$2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$409.3 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2022 to 2030.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.6% and 2.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$343.3 Million by the year 2030.
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel.
Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year.
Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.
Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
What`s New for 2023?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- Impact of Covid-19 and a Looming Global Recession
- Prevalence of Chronic Diseases Among the Growing Global Population Pushes Up the Diagnostic Burden & Demand for Imaging
- Rising Prevalence of Chronic Diseases Amplifies the Volume of Imaging Procedures, Driving Opportunities for Imaging Agents
- The US$ 37 Billion Robustly Growing Medical Imaging Market Provides Lucrative Opportunities for Contrast Agents for Advanced Visualization
- Aging Population, a Demographic Catalyst Driving Demand for Imaging Services
- Rapidly Aging Population & the Challenges Associated With Geriatric Imaging Spurs Demand for Contrast Imaging Agents
- Rise of Nuclear Medicine, the Cornerstone for the Growth for Radioactive Tracers
- Improving Quality & Value of Nuclear Medicine Bodes Well for Radioactive Contrast Agents
- Short Supply of Technetium-99m Threatens to Impact Nuclear Imaging Services
- Plagued by the Risk of Reactor Decommissioning & Unplanned Maintenance Shutdowns, Fragile Supply of Mo-99 Will Remain a Cause for Concern
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
MARKET TRENDS & DRIVERS
- Migration to Value Based Care Throws the Focus on Quality & Value of Imaging & Its Ability to Improve Patient Care by Providing Better Quality Images
- With "Value" being the new Currency in Healthcare Markets Worldwide, Value Based Imaging Will Positively Impact Contrast Enhanced Imaging Procedure
- Growing Preference for Non-Ionizing Radiation-Based Radioimaging Drives Demand for Contrast Enhanced MRI
- Commercially Available MRI Contrast Agents
- Spurred by Safety & Efficiency Benefits, Growing MRI Procedures & Parallel Increase in MRI Machines to Benefit Demand for MRI Contrast Agents
- Equipment Density Correlates With Number of Imaging Procedures
- Evolving Clinical Applications of Contrast-Enhanced Ultrasound (CEUS) Drive Demand for Ultrasound Contrast Agents
- Clinically Available Ultrasound Contrast Agents
- Growing Use of CEUS in Emergency and Critical Care
- Special Focus on Microbubble Contrast Agents for Ultrasound Imaging
- Clinical Applications of Microbubbles
- Oscillating Microbubbles: To Revolutionize Ultrasound
- Growing Market for Ultrasound Equipment Pushes Up the Number of CEUS Procedures Performed
- Continued Value of CT Imaging in Cardiology Despite Risk of Radiation Exposure Drives Demand for Contrast-Enhanced CT
- Contrast Agents Used in CT Imaging by Class: A Snapshot
- CCTA Gaining Traction in Coronary Arteries Imaging
- List of Iodine-Containing Contrast Agents for Coronary CT Angiography
- Growing Access to CT Imaging Bodes Well for CT Contrast Agents
- Rise in Image Guided Surgeries Drives Demand for Contrast Agents
- Emergence of Molecular-Targeted Fluorescent Tracers
- Select Potential "always-on" Targeted Tracers for Fluorescence Image-Guided Surgery (FIGS)
- The Use of Gold Nanoclusters as Contrast Agent for IGS of Head and Neck Tumors
- Better Surgical Outcome Drives the Number of Image Guided Surgeries Performed Worldwide Along with Demand for Contrast Agents
- Stringent Guidelines & Implementation of Best Practices for Safe Use of Contrast Agents to Encourage Patient Acceptance of Contrast Enhanced Imaging
- Safety Issues with Iodinated Agents, Gadolinium BCA and Microbubbles
- Symptoms of Reaction to Administration of Iodinated Contrast Media Agents
- Innovations Remain Crucial to Growth
- A Review of Advancements in Contrast Media Injector Technology
- Development of New Contrast Agents
- Key Challenges Confront the Market
- Advances in Imaging Technology Reduce Contrast Media Use
- Product Recalls and Side Effects of Contrast Media Challenge Growth
- A Snapshot of Side Effects, Allergic and Adverse Reactions with Contrast Agents
FOCUS ON SELECT PLAYERS (Total 45 Featured)
- AMAG Pharmaceuticals, Inc. (USA)
- Bayer Healthcare LLC (USA)
- Bracco Imaging SpA (Italy)
- GE Healthcare (USA)
- Genovis AB (Sweden)
- Guerbet Group (France)
- J.B. Chemicals & Pharmaceuticals Ltd. (India)
- Jodas Expoim (India)
- Lantheus Medical Imaging, Inc. (USA)
- Magnus Health (India)
- Medtronic Plc. (Ireland)
- nanoPET Pharma GmbH (Germany)
- Sanochemia Pharmazeutika AG (Austria)
- Spago Nanomedical AB (Sweden)
- Taejoon Pharm Co., Ltd. (South Korea)
- Unijules Life Sciences Ltd. (India)
For more information about this report visit https://www.researchandmarkets.com/r/uhhjyv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:SOURCE Research and Markets
